Static

Capillus HairBand Review: Good Looks, Awkward Fit

First reported by Wired ·

The signal ●○○○ Compiled by AI from Wired, the single source so far
Why you might care

This $600 headband requires 15 minutes of use per session and may slip off if not held in place.

What happened

Capillus has released a new red-light therapy headband, the HairBand, priced at $600, aiming for a more discreet design compared to other hair growth devices. Unlike helmets or bulky headpieces, the HairBand resembles a standard fabric headband with a small battery pack. It utilizes 82 laser diodes, a departure from LED technology, for a more focused treatment. Capillus suggests its design targets common hair loss areas like the hairline and temples. However, testing revealed significant drawbacks, including a small coverage area, a tendency to slip due to the battery pack's weight, and a lengthy treatment time of 15 minutes per session. The device is also not yet FDA-cleared, with Capillus targeting clearance for 2027, though its cap-style devices are already cleared.

What it means

The Capillus HairBand attempts to solve the aesthetic problem of red-light therapy devices by offering a sleek, discreet design that resembles a normal accessory. This signals a potential market shift towards integrating therapeutic technology more seamlessly into daily wear, moving away from overtly medical or sci-fi appearances. However, the device's practicality is questioned, with a limited coverage area and a design that compromises stability for aesthetics, suggesting that form may still be hindering function in this category.

The $600 price point, combined with the lack of FDA clearance and a cumbersome user experience, positions the Capillus HairBand as a niche product. Its reliance on laser diodes offers a more targeted approach than LEDs, but the practical challenges in application may limit its appeal to consumers seeking convenience alongside efficacy. The company's timeline for FDA clearance in 2027 indicates a longer development cycle for consumer-facing therapeutic devices and highlights the evolving regulatory landscape for such products.

AI-written summary. May contain errors.

Dev